Officer Paula Green Files Form 144 for $877K Stock Sale Amidst Broader Insider Distribution and Capital Raises
TWST has more than doubled off its 52-week low of $23.3.
Summary
Officer Paula Green filed a Form 144 to sell approximately $877,123 worth of common stock, adding to a series of insider selling disclosures today from multiple officers and significant capital raising activities.
Key Events · Ownership and Investor Activity · TWST
-
Proposed Stock Sale
Officer Paula Green filed a Form 144 to sell 16,739 shares of common stock, valued at approximately $877,123.
-
Cumulative Insider Selling
This filing contributes to a pattern of significant insider selling today, with Paula Green filing for a total of over $2 million and Officer Patrick Finn filing for $3.56 million in proposed sales.
-
Broader Capital Activity
These insider sales occur on the same day as the company's filings to issue approximately $30.17 million in common stock and register an additional $32.77 million for resale by selling stockholders.
-
Timing Near 52-Week Highs
The proposed sales by officers are occurring while Twist Bioscience's stock is trading near its 52-week high, potentially indicating a move to lock in gains.
Analysis · TWST · Life Sciences
This Form 144 from Officer Paula Green indicates an intent to sell an additional $877,123 in common stock. This filing is part of a significant day of capital activity and insider selling for Twist Bioscience. Alongside this, Green filed another Form 144 for $1.18 million, and Officer Patrick Finn filed for $3.56 million, totaling over $5.6 million in proposed insider sales. These insider dispositions coincide with the company's recent filings to issue approximately $30.17 million in common stock and register an additional $32.77 million for resale by selling stockholders. The proposed sales by officers are occurring while the stock is trading near its 52-week high, which could be interpreted as officers capitalizing on favorable market conditions. Investors should consider this pattern of insider selling in the context of the company's broader capital raising efforts.
At the time of this filing, TWST was trading at $51.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $23.30 to $53.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.